Has J Dean Cole, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,208,198 in general payments to J Dean Cole, MD across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean J Dean Cole, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about J Dean Cole, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

J Dean Cole, MD

Orthopaedic Trauma · Orlando, FLNPI 1285629568

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $4,203,374 of the $4,208,198 with a category attached, or 99.9%. 9 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 53.6% of the total. Reporting peaked in 2022 at $770,547 and has fallen 74.5% since, to $196,125 in 2025. Among orthopaedic trauma clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,208,198in general payments, 2019–2025

Across 113 payments — averaging $37,241 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$2.3M
Stryker$1.9M
Zimmer Biomet$30K
Reel Surgical, Inc.$4K
Orthofix Medical, Inc.$3K
Smith+Nephew$698
plus $170 from 3 others

$218,139in research payments, 2019–2025

Across 14 payments — averaging $15,581 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$185K
Zimmer Biomet$33K

What the payments were for

Royalty or licence$4,203,374100%
Travel & lodging$5060%
Food & beverage$7180%
Education$3,6000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	27	$2,254,474
Stryker	50	$1,915,942
Zimmer Biomet	21	$30,013
Reel Surgical, Inc.	3	$3,600
Orthofix Medical, Inc.	3	$3,301
Smith+Nephew	5	$698
Pacira Pharmaceuticals Incorporated	1	$123
Arthrex	2	$30
Johnson & Johnson	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

T2$1,915,631
EX NAILS$424,473
EXPert Nail$375,645
Versanail$29,139
ISKD (Intramedullary Skeletal Kinetic Distractor)$1,797
SKYHAWK$1,505
Affixus$783
REAL INTELLIGENCE$620
Iovera$123

How this compares

$4,208,198 in reported general payments places this provider in the 95th percentile of 65 orthopaedic trauma providers in Florida.

See all orthopaedic trauma providers in Florida →

Medicare billing

Part B allowed, 2024

$314,150

Medicare patients

390

Services billed

2,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tranexamic Acid	39	$1,566
Celecoxib	30	$446
Cefazolin Sodium	11	$338
Oxycodone Hcl	53	$273
Gabapentin	29	$206
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$141
Tramadol Hcl	25	$98
Methocarbamol	24	$96
Amoxicillin	70	$75
Meloxicam	23	$67
Clindamycin Hcl	12	$39
Prednisone	32	$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Orlando

Vuong NguyenOrlando$1.4M
Kenneth KovalOrlando$321K
Mohamed ShaathOrlando$303K
Frank AviluceaOrlando$191K
Barrett HawkinsOrlando$26K
Jonathan YawmanOrlando$9K
Edward PerezFt Lauderdale$981K
Hassan MirTemple Terrace$877K
Daniel SeginaMelbourne$330K
Daniel DziadoszSt Petersburg$262K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →